NYSE:MCKHealthcare
McKesson’s ASCO 2026 Data Highlights Evolving Role In Community Oncology
McKesson (NYSE:MCK) supported new research presented at ASCO 2026 by The US Oncology Network.
The study found that advanced practice provider led consult models can significantly improve patient access in community oncology.
Findings also indicate higher physician capacity when these consult models are used in real world clinic settings.
This is a fresh data point on how McKesson is involved in reshaping care delivery for cancer patients.
For investors tracking McKesson as more than a...